-
Company Profile
Epic Games Inc – Company Profile
Epic Games Inc (Epic Games) is a technology company that develops video games. The company provides an end-to-end digital ecosystem for developers and creators to build, distribute and operate games and other contents through epic games store and epic online services. It also offers interactive entertainment and three-dimensional (3D) engine technology. The company provides games such as battle breakers, fall guys, fortnite, infinity blade, robo recall, rocket league, shadow complex and unreal tournament, among others. It offers its services to...
Add to Basket -
Company Profile
GE T&D India Ltd – Company Profile
GE T&D India Ltd (GE T&D India), a subsidiary of General Electric Co, is a provider of power transmission infrastructure. The company offers turnkey solutions for power transmission, high voltage direct current (HVDC), flexible alternating current transmission system (FACTS), and network management system. Its product portfolio includes power transformers, circuit breakers, gas insulated switchgears, instrument transformers, substation automation, protection relays, power system automation equipment. It also provides digital solutions like energy management, automation, protection and asset management. The company has...
Add to Basket -
Product Insights
Wilson Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Wilson disease is a rare autosomal recessive inherited disorder of copper metabolism that is characterized by excessive deposition of copper in the liver, brain, and other tissues. Symptoms include abdominal pain, jaundice, problems with speech and swallowing, and muscle stiffness. Treatment includes chelators and Vitamin E supplements. The Wilson disease pipeline market research report provides comprehensive information on the therapeutics under development for Wilson disease, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – HY-005B8a
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry HY-005B8a Drug Details HY-005B8a is under development for the treatment of skin and soft...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – HY-004B8b
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry HY-004B8b Drug Details HY-004B8b is under development for the prevention of post-surgical nasal methicillin...
-
Product Insights
Ventricular Tachycardia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Ventricular tachycardia is a very fast heart rhythm that begins in the ventricles. Symptoms of ventricular tachycardia include dizziness, fainting, fatigue, chest pain, and shortness of breath. Causes include cardiomyopathy, ischemic heart disease, and heart failure. Risk factors include age, family history, and medical history. Treatment includes antiarrhythmic medication. The Ventricular Tachycardia pipeline drugs market research report provides comprehensive information on the therapeutics under development for Ventricular Tachycardia, complete with analysis by stage of development, drug target, mechanism of action...
-
Product Insights
Idiopathic Pulmonary Fibrosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Idiopathic Pulmonary Fibrosis (IPF) symptoms include dry cough, shortness of breath, especially during or after physical activity, lasting tiredness, and weight loss. Treatment includes antioxidants, biological response modulators, anti-fibrotic agents, and anticoagulants. The IPF pipeline drugs market research report provides an analysis of the IPF drugs by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide also covers the descriptive pharmacological action of the therapeutics, its complete research and development history...
-
Product Insights
Hepatitis D Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hepatitis D – Drugs In Development, 2022, provides an overview of the Hepatitis D (Infectious Disease) pipeline landscape. Hepatitis D, also known as the delta virus, is an infection that causes liver to swell. It is caused by the hepatitis D virus (HDV). Symptoms include yellowing of skin and eyes, joint pain, abdominal pains, vomiting, loss of appetite and fatigue. Risk factors include receiving many blood transfusions, abusing intravenous (IV)...
-
Product Insights
Actinic (Solar) Keratosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Actinic Keratosis Pipeline Drugs Market Overview An actinic keratosis, also known as solar keratosis, is a scaly or crusty growth (lesion). It most often appears on the bald scalp, face, ears, lips, backs of the hands and forearms, shoulders, neck, or any other areas of the body frequently exposed to the sun. The predisposing factors include age, sunny climate, history of frequent or intense sun exposure or sunburn, pale skin, red or blond hair, blue or light-colored eyes, and a...